Deciphering Options for TRT and Managing Withdrawal



1713390173013.webp


Screenshot (34619).png


Jesse N. Mills, MD, discusses the importance of testosterone replacement therapy and presents an algorithm for determining treatment and managing withdrawal. He begins with an overview of the history of the study of testosterone, from the first recorded effects of castration to the warning against the over-prescription of testosterone therapy issued in 2015 by the FDA.
Dr. Mills discusses the AUA guidelines for testosterone replacement therapy and the lack of on-label options for treatment. He presents options for on-and-off-label testosterone replacement therapy.

Dr. Mills then presents an algorithm for determining the best treatment option for the patient, beginning by addressing male fertility concerns. He addresses questions of lab work, transference, insurance, administration, and other patient and physician concerns.

Dr. Mills concludes with the discontinuation of testosterone replacement therapy and when it is indicated. He discusses the available options for weaning patients off of testosterone, cautioning strongly against abrupt discontinuation.
 
Screenshot (34624).webp




He has nothing against/uses compounded therapies.

As we all know compounded therapies are a great option!


*Keep in mind this was an older study done on compounded transdermal gels/creams from Canadian pharmacies
Screenshot (34625).webp
 

Online statistics

Members online
2
Guests online
353
Total visitors
355

Latest posts

Back
Top